Search results
Results from the WOW.Com Content Network
It was established as Clinical Lymphoma in 2000, renamed to Clinical Lymphoma & Myeloma in 2005 and obtained its current name in 2010. The journal covers research on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia, and related disorders, including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias.
Chemogenetics is the process by which macromolecules can be engineered to interact with previously unrecognized small molecules. Chemogenetics as a term was originally coined to describe the observed effects of mutations on chalcone isomerase activity on substrate specificities in the flowers of Dianthus caryophyllus. [1]
The use of rituximab has been established for the treatment of B-cell–derived hematologic malignancies, including follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). [ 7 ] In addition to cure-directed treatment, people can benefit from self-care to manage symptoms.
Genetics is a monthly scientific journal publishing investigations bearing on heredity, genetics, biochemistry and molecular biology. Genetics is published by the Genetics Society of America . It has a delayed open access policy, and makes articles available online without a subscription after 12 months have elapsed since first publication.
Clinical Genetics is a monthly peer-reviewed medical journal covering medical genetics. It was established in 1970 and is published by Wiley-Blackwell. The editor-in-chief is Reiner A. Veitia (University of Paris).
Chemotherapy: International Journal of Experimental and Clinical Chemotherapy is a peer-reviewed medical journal covering antimicrobial chemotherapy, published by Karger Publishers. The journal was established in 1960 and was originally named Chemotherapia , obtaining its current name in 1968.
Leukemia & Lymphoma is a peer-reviewed medical journal published by Informa Healthcare. It covers basic and clinical aspects of hematologic malignancies (leukemias and lymphomas). The editors-in-chief are Aaron Polliack (Hadassah University Hospital), Koen Van Besien (Weill Cornell Medical Center), and John Seymour (Peter MacCallum Cancer Centre).
Cancer Chemotherapy and Pharmacology is a peer-reviewed medical journal covering oncological pharmacotherapy. It was established in 1978 and is published by Springer Science+Business Media. The editors-in-chief are Jan Hendrik Beumer (University of Pittsburgh School of Pharmacy) and Étienne Chatelut (Institut Claudius-Regaud).